Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells. - Wikidata - awgldk - TriplyDB

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

http://www.wikidata.org/entity/Q35040623

about

Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.Systematic analysis of time-series gene expression data on tumor cell-selective apoptotic responses to HDAC inhibitors.Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.Silencing of ZNF139-siRNA induces apoptosis in human gastric cancer cell line BGC823.H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation Artesunate reduces serum lipopolysaccharide in cecal ligation/puncture mice via enhanced LPS internalization by macrophages through increased mRNA expression of scavenger receptors.Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells.Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism.In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells.Effects of TNF-α on Cementoblast Differentiation, Mineralization, and Apoptosis.Synthesis of an anthraquinone derivative (DHAQC) and its effect on induction of G2/M arrest and apoptosis in breast cancer MCF-7 cell line.Targeting of growth factors in the treatment of hepatocellular carcinoma: The potentials of polysaccharides.Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression.Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.Preventive Effect of Dihydromyricetin against Cisplatin-Induced Nephrotoxicity In Vitro and In Vivo.Molecular mechanisms of ampelopsin from Ampelopsis megalophylla induces apoptosis in HeLa cells.The Versatile Effects of Dihydromyricetin in Health.Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells Salidroside could enhance the cytotoxic effect of L‑OHP on colorectal cancer cells.

P2860

Q28546762-16FC9F06-13B8-457F-817E-095D00413963 Q33594379-1713BEA6-47F2-498B-A19F-89110365862B Q34008657-F6841DC0-5A06-4DCF-A643-A4AC3E5DF808 Q34059067-9D419711-9B8B-45ED-90CD-6A5B0AEE40F1 Q34413200-385CEB9B-78CB-43C9-AB81-8D5445CE4CA6 Q34731294-D8122283-7C35-459C-94C9-9176FAF8B30C Q36375113-DC02AF7F-1B7D-4B36-89A3-68A145BCB826 Q36827714-3C031B3E-8910-4992-97D3-0E98A5E86E26 Q37535601-0DE8F838-4C56-4F07-9E9D-5BCA8B9FF661 Q37581764-64AA7325-51A8-402F-97F1-17F5CC4625C0 Q37644922-38F1AA3F-7C11-4F36-980C-B0350904E3A3 Q37695478-86EEAADA-CDF1-4E16-A38E-1F398BC9DC33 Q38705755-F61C0275-8C7A-414A-951A-D5E8B906A8F7 Q38862387-617210D1-02A6-4693-B7D0-850E06689F36 Q38904379-9738692B-76FA-4D21-8D20-A503447F8BCC Q39270408-C7B0410E-8793-417A-8FD6-D0CBB5BB04C2 Q39338015-9907A01F-5167-4F60-9E24-5FEF1C85CFF1 Q40545073-FB12E062-973D-4170-89E3-551662C9C5D9 Q41027635-C72BCCE2-3E26-413E-B982-49A302C2F28F Q41612931-68CC2E0B-78FC-4921-88EB-131193253729 Q41692078-FD6FAA8C-1B15-4C44-860D-37F2497AA961 Q42555334-00914A58-A9B6-49E8-8544-74E442AF48B0 Q47427503-D185941F-D2FF-4BA6-B260-4B17BCEB549A

P2860

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

http://www.wikidata.org/entity/Q35040623

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

@ast

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

@en

type

label

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

@ast

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

@en

prefLabel

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

@ast

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

@en

P1433

Q35040623-683517F7-CD71-409D-B846-EA1BDF6611D6

P1476

Q35040623-7C818594-4B89-41BC-B04B-C8FF5F757637

P2093

Q35040623-3EC2C5DE-4023-4AEA-875D-D40F597AF745

Q35040623-40AE224B-ECBE-428B-8301-5855FFC25A79

Q35040623-56753C15-7243-443D-9D3F-85E50BFE2AB2

Q35040623-7F2A8460-343B-4A73-A2C1-F247325DE7DA

Q35040623-818FD89A-379F-413F-972B-2F6B18D0BE4E

Q35040623-9543D0B0-F0FD-4A78-B02A-8E3585834752

Q35040623-DFE63D31-6076-4EC4-8B65-6EB95A8E575E

Q35040623-E4D2B87D-21D0-438B-BB96-C1FFD0449C58

Q35040623-F62FED04-60E5-4333-A016-6E416E436739

P2860

Q35040623-06DE0E81-104C-4CBF-B3A4-3EAA24DBCBD6

Q35040623-0A2899FF-AD9B-492F-82AD-199EBC08F38B

Q35040623-132D8495-F7D3-403E-9CD5-E0A94292620A

Q35040623-15655B29-1E95-46DF-86FF-87636FB54C66

Q35040623-1D499131-1E97-43EB-9E77-2EEF62D7BC3C

Q35040623-2945CCB6-AA05-40C8-AC16-02990E336BA3

Q35040623-2E826F7D-39B0-4E13-8DA2-86353528155E

Q35040623-37073FB3-3B42-49AE-B347-17C94D6F306D

Q35040623-3D3CF6D0-492A-4458-B166-FCFCAA8130D6

Q35040623-476F54DC-83B9-4843-9D51-E34DBC5E4B47

P304

Q35040623-98281CD5-F305-4EBB-A25F-7262586EC3D8

P31

Q35040623-1A5624CA-09BC-4490-9CA8-1C382A97D328

P356

Q35040623-0B372925-463F-4811-82C9-90BBE65FC333

P407

Q35040623-DA5EA676-498C-495B-9031-7850EF466D06

P433

Q35040623-413385BE-1AD3-4502-811C-2B39BC2D0120

P478

Q35040623-342BA371-C847-44C0-846A-194275D419CF

P577

Q35040623-2FEC0F7A-FE9B-4FCA-860A-1C383779B603

P5875

Q35040623-E6B885E5-91F9-4B8A-B20F-58B7E37A49A1

P698

Q35040623-BED19094-A0C6-446D-A681-D4BBFB5C81A3

P932

Q35040623-C4E82ACA-7E61-46F1-B3BE-A2AB7E7DCF2D

P356

JOURNAL.PONE.0076886

P1433

P1476

Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

@en

P2093

Bin Liu

http://www.w3.org/2001/XMLSchema#string

Chang Wang

http://www.w3.org/2001/XMLSchema#string

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Mingyi Li

http://www.w3.org/2001/XMLSchema#string

Qingyu Zhang

http://www.w3.org/2001/XMLSchema#string

Runzhi Zhu

http://www.w3.org/2001/XMLSchema#string

Shiting Bao

http://www.w3.org/2001/XMLSchema#string

Shixing Wu

http://www.w3.org/2001/XMLSchema#string

Wei Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway

The genetics of the p53 pathway, apoptosis and cancer therapy.

Genomic instability--an evolving hallmark of cancer

Modes of p53 regulation

Synthesis and characterization of ampelopsin glucosides using dextransucrase from Leuconostoc mesenteroides B-1299CB4: glucosylation enhancing physicochemical properties.

Review of P-gp inhibition data in recently approved new drug applications: utility of the proposed [I(1) ]/IC(50) and [I(2) ]/IC(50) criteria in the P-gp decision tree.

Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells.

Flavonoid ampelopsin inhibits the growth and metastasis of prostate cancer in vitro and in mice

Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.

Sepia ink oligopeptide induces apoptosis in prostate cancer cell lines via caspase-3 activation and elevation of Bax/Bcl-2 ratio

P304

e76886

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0076886

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258504654

http://www.w3.org/2001/XMLSchema#string

P698

24223706

http://www.w3.org/2001/XMLSchema#string

P932

3817187

http://www.w3.org/2001/XMLSchema#string